The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 685K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
 
Synthesis of FK506-Cyclosporin hybrid macrocyclesEBI
TBA
Augmented photoswitching modulates immune signaling.EBI
Max Planck Research Unit For Enzymology of Protein Folding
Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands.EBI
Abbott Laboratories
Synthesis and biological evaluation of novel cyclosporin a analogues: potential soft drugs for the treatment of autoimmune diseases.EBI
Enanta Pharmaceuticals
Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicity.EBI
Merck Research Laboratories
C32-O-phenalkyl ether derivatives of the immunosuppressant ascomycin: a tether length study.EBI
Merck Research Laboratories
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.BDB
Sanofi Recherche